Are there adverse consequences of quizzing during informed consent for HIV research?

Journal of Medical Ethics

Volumn 37, Issue 11, 2011, Pages 693-697

  Sugarman, J ^a,b   Corneli, A ^c   Donnell, D ^d   Liu, T Y ^d   Rose, S ^c   Celentano, D ^e   Jackson, B ^b   Aramrattana, A ^f   Wei, L ^g   Shao, Y ^h   Liping, F ⁱ   Baoling, R ⁱ   Metzger, B Dye ^j  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f CHIANG MAI UNIVERSITY   (Thailand)

^g Guangxi Centers for Disease Prevention and Control   (China)

^h CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

ⁱ Xinjiang Autonomous Region Center for Disease Control and Prevention   (China)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; COMPREHENSION; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ETHICS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MALE; MEDICAL RESEARCH; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT; STANDARD; THAILAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMEDICAL RESEARCH; CHINA; COMMUNICATION; COMPREHENSION; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; THAILAND; YOUNG ADULT;

EID: 82955203444     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2011.042358     Document Type: Article

References (21)

1. Council for International Organization of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subject. Geneva: CIOMS/WHO, 2002.
2. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: U.S. Government Printing Office, 1979.
3. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Seoul: World Medical Association, 2008.
4. International Conference on Harmonization (ICH). Guideline for Good Clinical Practices. http://www.ich.org/products/guidelines/efficacy/article/efficacy-guideli nes.html (accessed 21 May 2011).
5. Taiwo OO, Kass N. Post-consent assessment of dental subject's understanding of informed consent in oral health research in Nigeria. BMC Med Ethics 2009;10:11.
6. Krosin MT, Klitzman R, Levin B, et al. Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa. Clin Trials 2006;3:302-13.
7. Breese PE, Burman WJ, Goldberg S, et al. Education level, primary language, and comprehension of the informed consent process. J Empir Res Hum Res Ethics 2007;2:69-79.
8. Lynöe N, Hyder Z, Chowdhury M, et al. Obtaining informed consent in Bangladesh. N Engl J Med 2001;344:460-1.
9. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001;358:1772-7.
10. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 1995;13:1062-72.
11. Sugarman J, McCrory DC, Powell D, et al. Empirical research on informed consent. Hastings Cent Rep 1999;29:S1-42.
12. Leach A, Hilton S, Greenwood BM, et al. An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med 1999;48:139-48.
13. Riecken HW, Ravich R. Informed consent to biomedical research in Veterans Administration Hospitals. JAMA 1982;248:344-8.
14. Vallely A, Lees S, Shagi C, et al. How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Med Ethics 2010;11:10.
15. Corneli A, McKenna K, Agot K, et al. Enhancing trial participants'understanding of informed consent for a phase 3 clinical trial on pre-exposure prophylaxis for HIV prevention. Abstract #THPE0534. XVIII International AIDS Conference. Vienna, Austria, 18-23 July 2010. http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200738616 (accessed 21 May 2011).
16. Coletti A, Kelly C, Coumi N, et al. Ongoing informed consent comprehension assessment: results of a pilot conducted in HPTN 035. Abstract #349. Pittsburgh, Pennsylvania: Microbicide, 22-25 May 2010. http://www.mtnstopshiv.org/sites/default/files/attachments/M2010%20Abstr acts-11-23-2010_0.pdf (accessed 21 May 2011).
17. MTN-003, The VOICE StudydVaginal and Oral Interventions to Control the Epidemic. http://www.mtnstopshiv.org/news/studies/mtn003 (accessed 29 Sep 2010).
18. Maarschalk S, Frohlich J, Ntombela F, et al. Structured tools for assessing for assisting literacy levels and comprehension assessment in the informed consent process; experiences from a microbicide trial in rural kwazulu natal, South Africa. Pittsburgh, Pennsylvania: Microbicide, 22-25 May 2010. Abstract #281. http://www.mtnstopshiv.org/sites/default/files/attachments/M2010%20Abstr acts-11-23-2010_0.pdf (accessed 21 May 2011).
19. HPTN 058: A Phase III Randomized Controlled Trial to Evaluate the Efficacy of Drug Treatment in Prevention of HIV Infection and Death Among Opiate Dependent Injectors. http://www.hptn.org/research_studies/hptn058.asp (accessed 29 Sep 2010).
20. Fiske DW. The subject reacts to tests. Am Psychol 1967;22:287-96.
21. Lounsbury JW, Bobrow W, Jensen JB. Attitudes toward employment testing: scale development, correlates, and "known-group" validation. Prof Psychol Res Pract 1989;20:340-9.